Valneva appoints dr. thomas decker and dr. michael pfleiderer to its scientific advisory board

Saint-herblain (france), may 31, 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, announced today the appointment of leading vaccine experts dr. thomas decker and dr. michael pfleiderer to its scientific advisory board (sab).
VALN Ratings Summary
VALN Quant Ranking